Eisai Co. v. Teva Pharmaceuticals USA, Inc.

180 L. Ed. 2d 818, 131 S. Ct. 2991, 564 U.S. 1001, 2011 U.S. LEXIS 4519, 79 U.S.L.W. 3696
CourtSupreme Court of the United States
DecidedJune 13, 2011
DocketNo. 10-1070
StatusPublished
Cited by4 cases

This text of 180 L. Ed. 2d 818 (Eisai Co. v. Teva Pharmaceuticals USA, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eisai Co. v. Teva Pharmaceuticals USA, Inc., 180 L. Ed. 2d 818, 131 S. Ct. 2991, 564 U.S. 1001, 2011 U.S. LEXIS 4519, 79 U.S.L.W. 3696 (U.S. 2011).

Opinion

On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal [819]*819Circuit with instructions to dismiss the case as moot. See United States v. Munsingwear, Inc., 340 U.S. 36, 71 S. Ct. 104, 95 L. Ed. 36 (1950).

Same case below, 620 F.3d 1341.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Azar v. Garza
584 U.S. 726 (Supreme Court, 2018)
Apotex, Inc. v. Daiichi Sankyo, Inc.
781 F.3d 1356 (Federal Circuit, 2015)
Dey Pharma, LP v. SUNOVION PHARMACEUTICALS INC.
677 F.3d 1158 (Federal Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
180 L. Ed. 2d 818, 131 S. Ct. 2991, 564 U.S. 1001, 2011 U.S. LEXIS 4519, 79 U.S.L.W. 3696, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eisai-co-v-teva-pharmaceuticals-usa-inc-scotus-2011.